GB202116644D0 - Liquid composition - Google Patents
Liquid compositionInfo
- Publication number
- GB202116644D0 GB202116644D0 GBGB2116644.2A GB202116644A GB202116644D0 GB 202116644 D0 GB202116644 D0 GB 202116644D0 GB 202116644 A GB202116644 A GB 202116644A GB 202116644 D0 GB202116644 D0 GB 202116644D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- liquid composition
- composition
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2116644.2A GB202116644D0 (en) | 2021-11-18 | 2021-11-18 | Liquid composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2116644.2A GB202116644D0 (en) | 2021-11-18 | 2021-11-18 | Liquid composition |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202116644D0 true GB202116644D0 (en) | 2022-01-05 |
Family
ID=79163977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2116644.2A Ceased GB202116644D0 (en) | 2021-11-18 | 2021-11-18 | Liquid composition |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202116644D0 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5708017A (en) | 1995-04-04 | 1998-01-13 | Merck & Co., Inc. | Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors |
EP0859612B1 (en) | 1995-09-21 | 2003-05-28 | Pharma Pass II LLC | Pharmaceutical composition containing an acid-labile omeprazole and process for its preparation |
WO2006031256A1 (en) | 2004-09-10 | 2006-03-23 | Santarus, Inc | A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
CN101288654A (en) | 2008-05-16 | 2008-10-22 | 北京正大绿洲医药科技有限公司 | Lansoprazole sustained-release drop pills and preparation method thereof |
JP2013028603A (en) | 2002-07-03 | 2013-02-07 | Takeda Pharmaceuticals Usa Inc | Liquid dosage form of proton pump inhibitor |
-
2021
- 2021-11-18 GB GBGB2116644.2A patent/GB202116644D0/en not_active Ceased
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5708017A (en) | 1995-04-04 | 1998-01-13 | Merck & Co., Inc. | Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors |
EP0859612B1 (en) | 1995-09-21 | 2003-05-28 | Pharma Pass II LLC | Pharmaceutical composition containing an acid-labile omeprazole and process for its preparation |
JP2013028603A (en) | 2002-07-03 | 2013-02-07 | Takeda Pharmaceuticals Usa Inc | Liquid dosage form of proton pump inhibitor |
WO2006031256A1 (en) | 2004-09-10 | 2006-03-23 | Santarus, Inc | A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
CN101288654A (en) | 2008-05-16 | 2008-10-22 | 北京正大绿洲医药科技有限公司 | Lansoprazole sustained-release drop pills and preparation method thereof |
Non-Patent Citations (5)
Title |
---|
"Handbook of Pharmaceutical Excipients", 1994 |
"Remington's Pharmaceutical Sciences", 1990, MACK PUBLISHING COMPANY |
DOOLAN: "Buffering lidocaine with sodium bicarbonate", AM J HOSP PHARM, vol. 51, no. 20, 15 October 1994 (1994-10-15), pages 2564 - 5 |
GEORGE ET AL., BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 48, no. 3, 2012, pages 577 - 581 |
SAMBROOK, J.RUSSEL, D.W.: "Molecular Cloning, A Laboratory Manual", 2001, COLD SPRING HARBOR LABORATORY PRESS |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202009247YA (en) | Liquid detergent composition | |
EP3909589C0 (en) | Liquid probiotic-herbal preparation | |
GB202004460D0 (en) | Herbical composition | |
GB202007377D0 (en) | Composition | |
EP4094582A4 (en) | Composition | |
GB202006093D0 (en) | Composition | |
GB202005911D0 (en) | Composition | |
GB202002786D0 (en) | Liquid pharmaceutical composition | |
GB202014635D0 (en) | Composition | |
GB202012895D0 (en) | Composition | |
SG11202105592XA (en) | Botulinum toxin-stabilizing liquid composition | |
GB202116644D0 (en) | Liquid composition | |
GB202000619D0 (en) | Composition | |
GB2605843B (en) | Liquid cleansing composition | |
EP4110374A4 (en) | Stable liquid dispersinb compositions | |
EP4069809A4 (en) | Liquid pearlescent composition | |
GB202102327D0 (en) | Liquid laundry composition | |
EP4230692A4 (en) | Composition | |
GB202114569D0 (en) | Composition | |
EP4043535A4 (en) | Liquid-crystal composition | |
GB201908813D0 (en) | Liquid concentrate composition | |
EP4115881A4 (en) | L-ergothioneine-containing composition | |
GB202102646D0 (en) | Composition | |
GB202102464D0 (en) | Composition | |
GB202102205D0 (en) | Composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |